NCT00810017 2022-05-19
Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer
Medstar Health Research Institute
Phase 2 Terminated
Medstar Health Research Institute
Barbara Ann Karmanos Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute